-
Johnson & Johnson Appoints Senior Leaders to Executive Committee
AmericanPharmaceuticalReview
December 10, 2021
Johnson & Johnson (announced the appointment of several senior leaders to the Company's Executive Committee. Separately, the Company announced that Mr. Michael Sneed, Executive Vice President, Global Corporate Affairs and Chief Communication Officer...
-
BioGeneration Ventures Fund III Reaches EUR 82 Million in Final Close
.b3cnewswire
April 23, 2019
Investments from Bristol-Myers Squibb and Johnson & Johnson Innovation - JJDC.
-
Financial Report: Johnson & Johnson
contractpharma
April 19, 2019
Pharmaceutical sales up 4% in the quarter despite declines for REMICADE and ZYTIGA.
-
Johnson & Johnson shares swoon as pharma giant loses yet another fight to protect Zytiga sales
fiercepharma
November 28, 2018
Johnson & Johnson lost its latest effort to fend off Zytiga generics in court, sending investors reeling at the prospect of losing blockbuster sales. But the pharma giant says it’s now planning a last-ditch stand at the U.S. Supreme Court.
-
Johnson & Johnson lifts annual guidance as third-quarter sales, profit top estimates
biospectrumasia
October 17, 2018
Top Story AL-8176 Darzalex Imbruvica Invega Sustenna Opsumit Prezista Remicade Simponi Stelara Tracleer Trevicta Uptravi Xarelto Xeplion Zytiga J&J Corporate Affairs
-
Johnson & Johnson suffers another cancer-suit loss as talc case count climbs above 9,000
fiercepharma
May 28, 2018
In the second trial loss for Johnson & Johnson's talc products in as many months, a jury in Los Angeles ordered the company and other defendants to pay $25.75 million in damages to plaintiff Joanne Anderson.
-
Johnson & Johnson Names Winners of First Africa Innovation Challenge
americanpharmaceuticalreview
March 15, 2017
Johnson & Johnson has named the winners of the first Africa Innovation Challenge at the Global Entrepreneurship Congress. The initiative, which received nearly 500 submissions from innovators and entrepreneurs across the continent, sought the best ideas f